Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Thymidine and deoxycytidine

EU orphan designation number: EU/3/17/1870   
Active ingredient: Thymidine and deoxycytidine
Indication: Treatment of mitochondrial DNA depletion syndrome, myopathic form
Sponsor: Vall d'Hebron Institute of Research
Pg. Vall d'Hebron 119-129, 08035 Barcelona, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/04/2017 Orphan designation EMA//OD/317/16 (2017)2789 of 20/04/2017
12/07/2017 Corrigendum (2017)2789 of 20/04/2017